HomeESLA • NASDAQ
add
Estrella Immunopharma Inc
Previous close
$1.11
Day range
$1.17 - $1.19
Year range
$0.63 - $3.23
Market cap
42.70M USD
Avg Volume
45.50K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.38M | 80.53% |
Net income | -3.38M | -80.53% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.80M | -91.88% |
Total assets | 3.74M | -86.34% |
Total liabilities | 2.99M | -82.70% |
Total equity | 746.29K | — |
Shares outstanding | 36.18M | — |
Price to book | 55.50 | — |
Return on assets | -206.17% | — |
Return on capital | -335.81% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -3.38M | -80.53% |
Cash from operations | -2.22M | -705.79% |
Cash from investing | — | — |
Cash from financing | -150.46K | -100.75% |
Net change in cash | -2.37M | -112.05% |
Free cash flow | 548.82K | -76.21% |
About
Founded
2006
Headquarters
Website
